Perspectives on metals-based radioimmunotherapy (RIT): moving forward

Moving forward: institutional perspectives on gender and entrepreneurship

Purpose The purpose of this paper is to propose a re-directed and purposeful attention to the design of research on gender and entrepreneurship moving forward. Design/methodology/approach The paper questions the value of more studies on the men v. women binary and encourages research on the institutions supporting the gendered construction. Findings The paper suggests a re-framing of gender (to...

Moving Forward

.......Having reached the end of my second term as editor in chief, the time has come for Micro to move forward to the next phase of its evolution. I am delighted to announce that Dr. Erik Altman from IBM Research is the new Micro EIC. Erik is an accomplished and highly respected industry architect and researcher who has held numerous leadership positions within the computing community. He has ...

Moving forward.

Radioimmunotherapy-based treatment of cancer

The principle of cancer immunotherapy includes various methods of manipulations to influence immune responses against tumors in both humans and animals. This advanced technology of hybridoma production provided the necessary skills to efficiently produce highly specific monoclonal antibodies (mAb). Radioactively-tagged antibodies which are applied in radioimmunotherapy (RIT), can target adjacen...

Pharmacokinetic analysis of an improved humanized monoclonal antibody designed for radioimmunotherapy ( RIT )

Many adenocarcinomas of the digestive tract develop from premalignant lesions, induced by bacteria, chemicals or nutritional components. Early detection, differential analysis and treatment of these cancer precursors is very often crucial for survival. Conventional human hybridoma technology offers the unique possibility to generate new fully human monoclonal antibodies for diagnosis and therap...